共 50 条
- [22] In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443) ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2007, 57 (04): : 218 - 226
- [24] N-[(R)-(6-Bromo-2-methoxyquinolin-3-yl)(phenyl)methyl]-N-[(S)-1-(4-methoxyphenyl)ethyl]-2-(piperazin-1-yl)acetamide ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2921 - U365
- [25] 2-(1-Ethyl-5-methoxy-1H-indol-3-yl)-N-(4-methoxyphenyl)-2-oxoacetamide ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O358 - U546
- [27] N-(5-Chloro-3-methyl-1-phenylpyrazol-4-ylcarbonyl)-N′-(2-methoxyphenyl)thiourea ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : O609 - U1304
- [28] HIV-1 REVERSE-TRANSCRIPTASE - INHIBITION BY 2',5'-OLIGOADENYLATES BIOCHEMISTRY, 1993, 32 (45) : 12112 - 12118
- [29] N-[2-(4-methylphenyl)ethyl]-N′-[2-(5-bromopyridyl)]-thiourea as a potent inhibitor of NNRTI-resistant and multidrug-resistant human immunodeficiency virus type 1 ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2000, 11 (02): : 135 - 140
- [30] (E)-2-(4-Methoxyphenyl)-N-(2-pyridyl)-3-(2-pyridylamino)acrylamide ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : O672 - U1293